Systemic lupus erythematosus

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 6, 2010, Pages 841-855

  O'Neill, Sean ^a   Cervera, Ricard ^b  

^a LIVERPOOL HOSPITAL   (Australia)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

environment; epidemiology; genetic; infections; systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; HAIR DYE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY;

AFRICAN AMERICAN; AGE; ALCOHOL CONSUMPTION; ARTHRITIS; BLADDER CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DESCRIPTIVE RESEARCH; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; DRUG USE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DISEASE; MALAR RASH; MORBIDITY; MORTALITY; MOUTH ULCER; NEUROLOGIC DISEASE; NONHUMAN; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RASH; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREND STUDY;

CAUSALITY; COHORT STUDIES; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE; RISK FACTORS;

EID: 79958814986     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2010.10.006     Document Type: Review

References (130)

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. New England Journal of Medicine 2008;358(9):929-39. (Pubitemid 351397092)
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism 1982;25(11):1271-7. (Pubitemid 13221242)
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism 1997;40(9):1725.
4. Font J, Cervera R. 1982 revised criteria for classification of systemic lupus erythematosus-ten years later. Lupus 1993;2(5):339-41. discussion 43.
5. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Seminars in Arthritis & Rheumatism 1973;3(1):1-54.
6. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Archives of Internal Medicine 1974;134(6):1027-35.
7. Hochberg MC, Perlmutter DL, Medsger TA, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995;4(6):454-6. (Pubitemid 26008725)
8. Michet CJ, McKenna CH, Elveback LR, et al. Epidemiology of systemic lupus erythematosus and other connective tissues disease in Rochester, Minnesota, 1950 though 1979. Mayo Clin Proc 1985;60:105-13.
9. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. British Journal of Rheumatology 1985;24(2):147-54. (Pubitemid 15119251)
10. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Annals of the Rheumatic Diseases 1994;53(10):675-80. (Pubitemid 24330603)
11. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. Journal of Rheumatology 1990;17(9):1162-7.
12. McCarty DJ, Manzi S, Medsger Jr TA, et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis & Rheumatism 1995;38(9):1260-70.
13. Johnson AE, Gordon C, Palmer RG, et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis & Rheumatism 1995;38(4):551-8.
14. Uramoto KM, Michet Jr CJ, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis & Rheumatism 1999;42(1):46-50.
15. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scandinavian Journal of Rheumatology 1985;14(1):43-6. (Pubitemid 15119213)
16. Meddings J, Grennan DM. The prevalence of systemic lupus erythematosus (SLE) in Dunedin. New Zealand Medical Journal 1980;91(656):205-6. (Pubitemid 10122644)
17. Hochberg MC. Prevalence of systemic lupus erythematosus in England and Wales, 1981-2. Annals of the Rheumatic Diseases 1987;46(9):664-6.
18. Maskarinec G, Katz AR. Prevalence of systemic lupus erythematosus in Hawaii: is there a difference between ethnic groups? Hawaii Medical Journal 1995;54(2):406-9.
19. Samanta A, Roy S, Feehally J, et al. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. British Journal of Rheumatology 1992;31(10):679-82.
20. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus 1997;6(4):399-403. (Pubitemid 27232136)
21. Fukase M. The epidemiology of systemic lupus erythematosus in Japan. In: Fukase M, editor. Systemic lupus erythematosus. Baltimore: University Park Press; 1980. p. 3-10.
22. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, et al. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 1993;2(5):303-12.
23. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis & Rheumatism 1982;25(6):601-11.
24. Symmons DP. Frequency of lupus in people of African origin. Lupus 1995;4(3):176-8.
25. D'Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet 2007;369(9561):587-96. (Pubitemid 46241445)
26. Jonsson H, Nived O, Sturfelt G, et al. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. British Journal of Rheumatology 1990;29(3):185-8. (Pubitemid 20194017)
27. Naleway AL, Davis ME, Greenlee RT, et al. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14(10):862-6. (Pubitemid 41597626)
28. Lopez P, Mozo L, Gutierrez C, et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003;12(11):860-5. (Pubitemid 37463106)
29. Piette JC, Papo T, Amoura Z, et-al. Lupus erythematosus systemique. In: Traité de Medicine. 4th ed. Paris; 2004.
30. Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus 2003;12(4):327-31 [Erratum appears in Lupus. 2003;12(6):494].
31. Vasconcelos C. Epidemiologia clínica do lupus eritematoso sistémico; 2007. Oporto.
32. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 1993;72(2):113-24. (Pubitemid 23097765)
33. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine 1999;78(3):167-75.
34. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82(5):299-308. (Pubitemid 37229465)
35. Petri M. The effect of race on the presentation and course of SLE in the United States. Arthritis Rheum 1997;40:S162.
36. Alarcon GS, McGwin Jr G, Petri M, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002;11(2):95-101 [Erratum appears in Lupus 2002;11(6):402].
37. Wang F, Wang CL, Tan CT, et al. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997;6(3):248-53. (Pubitemid 27160643)
38. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis & Rheumatism 1997;40(5):809-13. (Pubitemid 27199995)
39. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis & Rheumatism 2005;52(5):1481-90. (Pubitemid 40663940)
40. Bernatsky S, Joseph L, Boivin JF, et al. The relationship between cancer and medication exposures in systemic lupus erythematosus: a case-cohort study. Annals of the Rheumatic Diseases 2008;67(1):74-9.
41. Gladman DD. Prognosis and treatment of systemic lupus erythematosus. Current Opinion in Rheumatology 1996;8(5):430-7. (Pubitemid 26393844)
42. Swaak AJ, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Annals of the Rheumatic Diseases 1989;48(6):447-54.
43. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis & Rheumatism 1995;38(2):274-83.
44. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis & Rheumatism 1995;38(10):1492-9.
45. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. Journal of Rheumatology 1995;22(7):1265-70.
46. Drenkard C, Villa AR, Alarcon-Segovia D, et al. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. Journal of Rheumatology 1994;21(6):1067-72. (Pubitemid 24182280)
47. Wallace DJ, Podell T, Weiner J, et al. Systemic lupus erythematosus-survival patterns. Experience with 609 patients. Journal of American Medical Association 1981;245(9):934-8. (Pubitemid 11154415)
48. Studenski S, Allen NB, Caldwell DS, et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis & Rheumatism 1987;30(12):1326-32.
49. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis & Rheumatism 1997;40(1):47-56. (Pubitemid 27044035)
50. Merrell M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chron Dis 1955;1:12-32.
51. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Seminars in Arthritis & Rheumatism 1991;21(1):55-64.
52. Anstey NM, Bastian I, Dunckley H, et al. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Australian & New Zealand Journal of Medicine 1993;23(6):646-51. (Pubitemid 2040904)
53. Gripenberg M, Helve T. Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations. Scandinavian Journal of Rheumatology 1991;20(2):104-9.
54. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Seminars in Arthritis & Rheumatism 1991;21(2):73-80.
55. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. Journal of Rheumatology 1995;22(7):1259-64.
56. Kellum RE, Haserick JR. Systemic lupus erythematosus. A statistical evaluation of mortality based on a consecutive series of 299 patients. Archives of Internal Medicine 1964;113:200-7.
57. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50(2):85-95.
58. Urowitz M, Bookman A, Koehler B, et al. The bimodal mortality pattern of systemic lupus erythematosus. The American Journal of Medicine 1976;60:221-5.
59. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Quarterly Journal of Medicine 1985;55(216):87-98. (Pubitemid 15105095)
60. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis & Rheumatism 1990;33(1):37-48.
61. Fries JF, Weyl S, Holman HR. Estimating prognosis in systemic lupus erythematosus. American Journal of Medicine 1974;57(4):561-5.
62. Cervera R, Khamashta MA, Hughes GRV. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009;18(10):869-74.
63. Molokhia M, Hoggart C, Patrick AL, et al. Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population. Human Genetics 2003;112(3):310-8. (Pubitemid 36869089)
64. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis & Rheumatism 1985;28(1):80-6.
65. Petri M. Hopkins lupus cohort. Rheumatic Diseases Clinics of North America 1999;26(2):199-213. update.
66. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among " Hispanics". Medicine 2004;83(1):1-17.
67. Lockshin MD. Sex differences in autoimmune disease. Lupus 2006;15(11):753-6.
68. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis & Rheumatism 2008;58(8):2511-7.
69. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis & Rheumatism 1992;35(3):311-8.
70. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis & Rheumatism 2005;52(4):1138-47. (Pubitemid 40530121)
71. Kelly JA, Kelley JM, Kaufman KM, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes & Immunity 2008;9(3):187-94. (Pubitemid 351584185)
72. International Consortium for Systemic Lupus Erythematosus Genetics, Harley JB, Alarcon-Riquelme ME, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics 2008;40(2):204-10.
73. Crow MK, Crow MK. Collaboration, genetic associations, and lupus erythematosus. New England Journal of Medicine 2008;358(9):956-61. (Pubitemid 351397097)
74. Scofield RH, Scofield RH. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Current Opinion in Rheumatology 2009;21(5):448-53.
75. Hewagama A, Richardson B, Hewagama A, et al. The genetics and epigenetics of autoimmune diseases. Journal of Autoimmunity 2009;33(1):3-11.
76. Doria A, Canova M, Tonon M, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmunity Reviews 2008;8(1):24-8.
77. Sebastiani GD, Galeazzi M. Infection-genetics relationship in systemic lupus erythematosus. Lupus 2009;18(13):1169-75.
78. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis & Rheumatism 2001;44(5):1122-6. (Pubitemid 32433618)
79. McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine 2005;11(1):85-9. (Pubitemid 40215842)
80. Edwards CJ, Syddall H, Goswami R, et al. Infections in infancy and the presence of antinuclear antibodies in adult life. Lupus 2006;15(4):213-7.
81. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis & Rheumatism 2004;50(3):849-57. (Pubitemid 38326185)
82. Freemer MM, King Jr TE, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Annals of the Rheumatic Diseases 2006;65(5):581-4.
83. Boeckler P, Cosnes A, Frances C, et al. Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Archives of Dermatology 2009;145(9):1012-6.
84. Kreuter A, Gaifullina R, Tigges C, et al. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. Archives of Dermatology 2009;145(3):244-8.
85. Simard JF, Costenbader KH, Liang MH, et al. Exposure to maternal smoking and incident SLE in a prospective cohort study. Lupus 2009;18(5):431-5.
86. Kardestuncer T, Frumkin H. Systemic lupus erythematosus in relation to environmental pollution: an investigation in an African-American community in North Georgia. Archives of Environmental Health 1997;52(2):85-90. (Pubitemid 27150451)
87. Registry AfTSaD. Petitioned Public Health Assessment - The Newtown Community. Division of Health Assessment and Consultation, Exposure Investigations Branch. Petitions Response Section. Agency for Toxic Substances and Disease Registry; 2001.
88. Balluz L, Philen R, Ortega L, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. American Journal of Epidemiology 2001;154(11):1029-36. (Pubitemid 33121621)
89. Wallace DJ, Quismorio Jr FP. The elusive search for geographic clusters of systemic lupus erythematosus. Critical review. Arthritis & Rheumatism 1995;38(11):1564-7.
90. Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization data. American Journal of Epidemiology 2000;151(11):1053-9. (Pubitemid 30489199)
91. Tsai P-C, Ko Y-C, Huang W, et al. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Science of the Total Environment 2007;374(2-3):216-22.
92. Griffin JM, Gilbert KM, Lamps LW, et al. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicological Sciences 2000;57(2):345-52.
93. Griffin JM, Blossom SJ, Jackson SK, et al. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 2000;46(2):123-37. (Pubitemid 30019254)
94. Cooper GS, Makris SL, Nietert PJ, et al. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environmental Health Perspectives 2009;117(5):696-702.
95. Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. International Immunopharmacology 2002;2(2-3):303-13. (Pubitemid 34075419)
96. Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus. Autoimmunity 2005;38(7):497-506. (Pubitemid 43101784)
97. Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus 2006;15(11):728-36.
98. Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis & Rheumatism 2002;46(7):1840-50 [Erratum appears in Arthritis Rheum. 2004 May;50(5):1694].
99. Cooper GS, Parks CG, Treadwell EL, et al. Occupational risk factors for the development of systemic lupus erythematosus. Journal of Rheumatology 2004;31(10):1928-33. (Pubitemid 39336715)
100. Bengtsson AA, Rylander L, Hagmar L, et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology 2002;41(5):563-71. (Pubitemid 34567188)
101. Hardy CJ, Palmer BP, Muir KR, et al. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study. Annals of the Rheumatic Diseases 1998;57(8):451-5. (Pubitemid 28428212)
102. Ghaussy NO, Sibbitt Jr WL, Qualls CR. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. Journal of Rheumatology 2001;28(11):2449-53. (Pubitemid 33031975)
103. Formica MK, Palmer JR, Rosenberg L, et al. Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study. Journal of Rheumatology 2003;30(6):1222-6. (Pubitemid 36666344)
104. Wang J, Kay AB, Fletcher J, et al. Alcohol consumption is not protective for systemic lupus erythematosus. Annals of the Rheumatic Diseases 2009;68(3):345-8.
105. Burry JN. Lipstick and lupus erythematosus. New England Journal of Medicine 1969;281(11):620-1.
106. Wang J, Kay AB, Fletcher J, et al. Is lipstick associated with the development of systemic lupus erythematosus (SLE)? Clinical Rheumatology 2008;27(9):1183-7.
107. Hardy CJ, Palmer BP, Muir KR, et al. Systemic lupus erythematosus (SLE) and hair treatment: a large community based case-control study. Lupus 1999;8(7):541-4. (Pubitemid 29452567)
108. Petri M, Allbritton J. Hair product use in systemic lupus erythematosus. A case-control study. Arthritis & Rheumatism 1992;35(6):625-9.
109. Cooper GS, Dooley MA, Treadwell EL, et al. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. Journal of Rheumatology 2001;28(12):2653-6. (Pubitemid 33135650)
110. Sanchez-Guerrero J, Karlson EW, Colditz GA, et al. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis & Rheumatism 1996;39(4):657-62.
111. Danila MI, Pons-Estel GJ, Zhang J, et al. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology 2009;48(5):542-5.
112. Manger K, Manger B, Repp R, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2002;61(12):1065-70. (Pubitemid 35397352)
113. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis & Rheumatism 2006;54(8):2550-7. (Pubitemid 44205016)
114. Lu LJ, Wallace DJ, Ishimori ML, et al. Review: male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus 2010;19(2):119-29.
115. Mody GM, Parag KB, Nathoo BC, et al. High mortality with systemic lupus erythematosus in hospitalized African blacks. British Journal of Rheumatology 1994;33(12):1151-3.
116. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. American Journal of Medicine 1991;91(4):345-53.
117. Alarcon GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis & Rheumatism 1998;41(7):1173-80.
118. Samanta A, Feehally J, Roy S, et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Annals of the Rheumatic Diseases 1991;50(7):490-2.
119. Sule S, Petri M. Socioeconomic status in systemic lupus erythematosus. Lupus 2006;15(11):720-3.
120. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. American Journal of Epidemiology 1997;145(5):408-15. (Pubitemid 27084212)
121. Roman MJ, Shanker B-A, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. New England Journal of Medicine 2003;349(25):2399-406 [see comment] [erratum appears in N Engl J Med. 2006 Oct 19;355(16):1746].
122. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis & Rheumatism 2001;44(10):2331-7 [see comment].
123. Bessant R, Hingorani A, Patel L, et al. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology 2004;43(7):924-9. (Pubitemid 38996970)
124. O'Neill SG, Pego-Reigosa JM, Hingorani AD, et al. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus. Rheumatology 2009;48(5):573-5.
125. Bruce IN. 'Not only.but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology 2005;44(12):1492-502.
126. Hahn BH. Systemic lupus erythematosus and accelerated atherosclerosis. New England Journal of Medicine 2003;349(25):2379-80 [see comment] [comment].
127. O'Neill SG, Giles I, Lambrianides A, et al. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis & Rheumatism 2010;62(3):845-54.
128. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis & Rheumatism 2006;54(8):2541-9 [see comment].
129. Bjornadal L, Yin L, Granath F, et al. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. Journal of Rheumatology 2004;31(4):713-9.
130. Lim SS, Drenkard C. Epidemiology of systemic lupus erythematosus: capturing the butterfly. Current Rheumatology Reports 2008;10(4):265-72.